Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
NHS To Offer Licensed Cannabis-Based Medicine To Treat Rare Genetic Condition
The NHS will be able to prescribe cannabidiol (Cannabis) to patients with a rare, seizure-causing […]
Major Plan to Recover Urgent and Emergency NHS Care Services
The NHS and the government will publish a new blueprint today to help recover urgent […]
NHS Delivers 20 Million Flu Jabs As Critical Care Cases Rise
More than 20 million people in England have had their flu jabs as the number […]
NHS Cuts Waiting Lists As A&E Departments Busier Than Ever Before
The NHS waiting list has fallen for the first time since the start of the […]
NHS England Appoints Leading Clinicians To Board
NHS England has added a wealth of clinical expertise and experience to its board with […]
A Record Year For People Receiving NHS Cancer Treatment
Thousands more people started vital treatment for cancer over the last year compared to before […]
Statement from Steve Barclay, Secretary of State for Health and Social Care
Health and Social Care Secretary Steve Barclay said: It is an honour to take up […]
World’s First Chemo Drone Delivery Announced on NHS Birthday
NHS cancer patients will be the first in the world to benefit from chemotherapy delivered […]
Digital Revolution to Bust COVID Backlogs and Deliver More Tailored Care for Patients
People across the country will benefit from faster, more personalised healthcare, following a digital revolution […]
Revolution in Care of Leukaemia as New Treatment Drug Approved for Cancer Patients
The charity Leukaemia Care today welcomes the news from the National Institute for Health and Care Excellence […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more